Sarah U. Morton, Ph.D. - Publications

Affiliations: 
2008 Biochemistry and Molecular Biology University of California, San Francisco, San Francisco, CA 
Area:
Biochemistry, Molecular Biology, Cell Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Morton SU, Shimamura A, Newburger PE, Opotowsky AR, Quiat D, Pereira AC, Jin SC, Gurvitz M, Brueckner M, Chung WK, Shen Y, Bernstein D, Gelb BD, Giardini A, Goldmuntz E, et al. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease. Jama Cardiology. PMID 33084842 DOI: 10.1001/jamacardio.2020.4947  0.72
2020 Sharma A, Wasson LK, Willcox JA, Morton SU, Gorham JM, DeLaughter DM, Neyazi M, Schmid M, Agarwal R, Jang MY, Toepfer CN, Ward T, Kim Y, Pereira AC, DePalma SR, et al. utations in hiPSCs inform mechanisms for maldevelopment of the heart, pancreas, and diaphragm. Elife. 9. PMID 33054971 DOI: 10.7554/eLife.53278  0.72
2020 Boskovski MT, Homsy J, Nathan M, Sleeper LA, Morton S, Manheimer KB, Tai A, Gorham J, Lewis M, Swartz M, Alfieris GM, Bacha EA, Karimi M, Meyer D, Nguyen K, et al. De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease. Circulation. Genomic and Precision Medicine. 13: e002836. PMID 32812804 DOI: 10.1161/CIRCGEN.119.002836  0.72
2020 Richter F, Morton SU, Kim SW, Kitaygorodsky A, Wasson LK, Chen KM, Zhou J, Qi H, Patel N, DePalma SR, Parfenov M, Homsy J, Gorham JM, Manheimer KB, Velinder M, et al. Genomic analyses implicate noncoding de novo variants in congenital heart disease. Nature Genetics. PMID 32601476 DOI: 10.1038/S41588-020-0652-Z  0.72
2020 Hsieh A, Morton SU, Willcox JAL, Gorham JM, Tai AC, Qi H, DePalma S, McKean D, Griffin E, Manheimer KB, Bernstein D, Kim RW, Newburger JW, Porter GA, Srivastava D, et al. EM-mosaic detects mosaic point mutations that contribute to congenital heart disease. Genome Medicine. 12: 42. PMID 32349777 DOI: 10.1186/S13073-020-00738-1  0.72
2017 Jin SC, Homsy J, Zaidi S, Lu Q, Morton S, DePalma SR, Zeng X, Qi H, Chang W, Sierant MC, Hung WC, Haider S, Zhang J, Knight J, Bjornson RD, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nature Genetics. PMID 28991257 DOI: 10.1038/Ng.3970  0.72
2009 Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 460: 705-10. PMID 19578358 DOI: 10.1038/Nature08195  0.72
2008 Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D. microRNA-138 modulates cardiac patterning during embryonic development. Proceedings of the National Academy of Sciences of the United States of America. 105: 17830-5. PMID 19004786 DOI: 10.1073/Pnas.0804673105  0.72
2008 Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Developmental Cell. 15: 272-84. PMID 18694566 DOI: 10.1016/J.Devcel.2008.07.008  0.72
2007 Mitchell DA, Morton SU, Fernhoff NB, Marletta MA. Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 11609-14. PMID 17606900 DOI: 10.1073/Pnas.0704898104  0.72
2006 Mitchell DA, Morton SU, Marletta MA. Design and characterization of an active site selective caspase-3 transnitrosating agent. Acs Chemical Biology. 1: 659-65. PMID 17168570 DOI: 10.1021/Cb600393X  0.72
Show low-probability matches.